P.A.W. Capital Corp Amgen Inc Transaction History

P.A.W. Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $92,284 - $102,696	-400 Reduced 10.0%	3,600 $876,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $795,520 - $910,400	4,000 New	4,000 $900,000
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $1.35 Million - $1.51 Million	-8,000 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $1.34 Million - $1.53 Million	8,000	8,000 $1.49 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.